Five global private equity firms, including Warburg Pincus, Permira, EQT, Bain, and TPG, are interested in bidding for Bharat Serums and Vaccines (BSV), which is seeking over $1 billion. The firms will sign expressions of interest soon and start due diligence on the Mumbai-based biopharmaceutical company. Advent International, the current owner, acquired BSV in 2019 and now wants to sell it. Some contenders may partner with pharmaceutical companies for the bid. Advent has engaged Jefferies and JP Morgan for the sale process.
Jagdale Healthcare announces recent clinical study results on Mulmina for its immune boosting benefits ANI | Updated: Dec 12, 2020 14:04 IST
Bengaluru (Karnataka) [India], December 12 (ANI/NewsVoir): Jagdale Healthcare, a subsidiary of Jagdale Industries, recently announced the results of a clinical study on their popular health drink Mulmina®. Suitable for consumption for all age groups, including children, Mulmina® is composed of natural superfoods and is the only ready to drink immune booster, antioxidant beverage in a tetra pack. The inherent immune-boosting properties of the drink make it an excellent alternative to suitable alternative to other health beverages. Each 200 ml pack of Mulmina® contains over 5000 ORAC units, which ensures 100% RDA of antioxidants.
Jagdale Healthcare announces clinical study results longbeachstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from longbeachstar.com Daily Mail and Mail on Sunday newspapers.